Smoking prevention and cessation policies

Tumors of the Chest: Biology, Diagnosis and Management

Volumn , Issue , 2006, Pages 627-639

  Gratziou, Christina ^a   Roussos, Charis ^b,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862997423     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-31040-1_54     Document Type: Chapter

References (48)

1. European Commission. European Opinion Research Group. Smoking and the environment: actions and attitudes. Special Euro barometer 183/Wave 58.2, 2003;1. http://europa.eu.int./comm/public-pinion/
2. World Bank. Curbing the epidemic: governments and the economics of tobacco control. Washington DC, 1999. wwwl.WorldBank.org/tobacco/chapterl.asp
3. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R. Mortality from smoking worldwide. Br Med Bull 1996;52:12.
4. European Respiratory Society (ERS). The burden of lung disease. In: Loddenkemper R, Gibson GJ, Sibille Y (eds) European Lung White Book: The First Comprehensive Survey on Respiratory Health in Europe. Sheffield, UK: ERSJ, 2003:7.
5. European Respiratory Society (ERS). Lung cancer. In: Loddenkemper R, Gibson GJ, Sibille Y (eds) European Lung White Book: The First Comprehensive Survey on Respiratory Health in Europe. Sheffield, UK: ERSJ, 2003:44.
6. World Health Organization (WHO). Guidelines for Controlling and Monitoring the Tobacco Epidemic. Publication draft. Geneva: WHO, 1995.
7. Europe against cancer programme. Official Journal 26/2/1987; C: 50:58.
8. European Commission. Tobacco or health in the European Union: the ASPECT Consortium. October 2004 http://europa.eu.int
9. CDC. Reasons for tobacco use and symptoms of nicotine withdrawal among adolescent and young adult tobacco users. Morbidity and Mortality Weekly Report 1994;43:745.
10. IASLC Workshop. Prevention and early detection of lung cancer. Clinical aspects proceedings. Elsinore, Denmark, 1996.
11. Lightwood JM, Glantz SA. Short term economic and health benefits of smoking cessation. Circulation 1997;96:1089.
12. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years observation on male British doctors. BMJ 2004;328:1519.
13. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild to moderate chronic obstructive pulmonary disease: the Lung Health Study. Am J Res Crit Care Med 2000;161:381.
14. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000;321:323.
15. World Health Organization (WHO). Tobacco or health: a global status report. Geneva: WHO, 1997.
16. Zhu SH, Melcer T, Sun J, et al. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med 2000;18:305.
17. Royal College of Physicians. Nicotine addiction in Britain. London: Royal College of Physicians, 2000.
18. Hughes JR, Gulliver SB, Fenwick JW, et al. Smoking cessation among self-quitters. Health Psychol 1992;11:331.
19. Fagerstrom K-O, Schneider N. Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire. I Behav Med 1989;12:159.
20. American College of Chest Physicians, American Thoracic Society, Asia Pacific Society of Respiratory, Canadian Thoracic Society, European Respiratory Society, International Union Against Tuberculosis and Lung Diseases Smoking and Health. A physician's responsibility: a statement of the joint committee on smoking and health. Eur Respir J 1995;8:1808.
21. USDHHS Tobacco and the Clinician Interventions for Medical and Dental Practice, NCL 94-3693. US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1994.
22. Fiore MC, Bailey WC, Cohen SJ, et al. Smoking cessation. Clinical practice guideline no. 18, AHCPR 96-0692. US Department of Health and Human Services, Public Health Service, Agency for Health Service, Agency for Health Care Policy and Research. The smoking cessation clinical practice guideline. Panel and staff. The Agency for Health Care Policy and Research. JAMA 1996;275:1270.
23. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: quick reference guide for clinicians. Rockville, MD: US Department of Health and Human Services. Public Health Service, 2000.
24. West R, McNeill A, Ras M. Smoking cessation guidelines for health professionals: an update. Thorax 2000;55:987.
25. World Health Organization (WHO). European partnership to reduce tobacco dependence: WHO evidence-based recommendations on the treatment of tobacco dependence. Geneva: WHO, 2001.
26. National Institute for Clinical Excellence (NICE). Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. National Institute for Clinical Excellence Technology Appraisal Guidance 2002;39. www.nice.org.uk
27. Andersson JE, Joremby DE, Scott WJ, Fiore MC. Treating tobacco use and dependence. Chest 2002;121:932.
28. Gratziou CH. The process of stopping smoking. European Respiratory Seminar on Smoking Cessation. European Respiratory Society School. Budapest Dec. 2004. www.ersnet.org/edu
29. Tonnesen P. Essential communication skills in individual smoking cessation. Review series: patient education. Chronic Respir Dis 2004;1:221.
30. Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994;271:1940.
31. Tonnessen P, Paoletti P, Gustavsson G, et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE-trial. Eur Respir J 1999;13:238.
32. West R. Bupropion SR for smoking cessation: expert opinion. Drug Evaluation 2003;533.
33. Coleman T, West R. Newly available treatments for nicotine addiction: smokers wanting help to stop smoking now have effective treatment options. BMJ 2001;322:1076.
34. Holm KJ, Spencer CM. Bupropion: a review of its use in the management of smoking cessation. Drugs 2000;59:1007.
35. Gratziou C, Francis K, Maragianni A, et al. Bupropion treatment and cognitive behavioral therapy in smoking cessation program. Eur Respir J 2001;12
36. Balfour DJK. The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion. Int J Clin Pract 2001;55:53.
37. Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 2000;295:321.
38. Hall S, Humeet G, Reus V, et al. Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry 2002;59:930.
39. Benowitz NL, Wilson Peng M. Non-nicotine pharmacotherapy for smoking cessation. Mechanisms and prospects. CNS Drugs 2000;13:265.
40. White A, Resch K, Ernst E. A metaanalysis of acupuncture techniques for smoking cessation. Tob Control 1999;8:393.
41. Lancaster T, Stead LF. Individual behavioral counselling for smoking cessation. Cochrane Database Syst Rev 2000;2:CD001292.
42. British Medical Association. Towards smoke-free public places. London: BMA, 2002.
43. Johnson E, Dominici F, Griswold M, et al. Disease cases and their medical costs attributable to smoking: an analysis of the national medical expenditure survey. J Econometrics 2003;112:135.
44. Ruff LK, Volmer T, Nowak D, et al. The economic impact of smoking in Germany. Eur Respir J 2000;16:385.
45. Parrott S, Godfrey C, Raw M, et al. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Thorax 1998;53:S1.
46. Godfrey C. The economic and social costs of lung cancer and the economics of smoking prevention. Monaldi Arch Chest Dis 2001;56:458.
47. WHO - World Health Organization. Economic consequences of smoking (ECOS) model. WHO European Partnership Project to Reduce Tobacco Dependence. Copenhagen-Geneva: WHO, 1999. http://www.who.dk/adt/ecos/whoweb.asp
48. Cromwell J, Bartosch WJ, Fiore MC, et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 1997;278:1759.